Nektar Therapeutics announced topline data from a Phase 2 randomized, double-blind, placebo-controlled study of rezpegaldesleukin in adults with moderately-to-severely active systemic lupus erythematosus (SLE)...
AtlantiCare is the first healthcare system in the northeastern U.S. to use Optellum's Virtual Nodule Clinic. Located in New Jersey, it is integrating the innovative technology into...
Artera, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, announced new data at ASCO GU 2023 demonstrating that its multimodal artificial intelligence...
Gilead Sciences, Inc. announced new and updated positive results from three cohorts of the Phase 2 TROPHY-U-01 study of Trodelvy for the treatment of...
Bristol Myers Squibb announced three-year follow-up results from the Phase 3 CheckMate -274 trial, demonstrating significant sustained clinical benefits with Opdivo (nivolumab) for the adjuvant...
